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IMPORTANCE—Microglia, the resident immune cells of the central nervous system, play an 
important role in the brain’s response to injury and neurodegenerative processes. It has been 
proposed that prolonged microglial activation occurs after single and repeated traumatic brain 
injury, possibly through sports-related concussive and subconcussive injuries. Limited in vivo 
brain imaging studies months to years after individuals experience a single moderate to severe 
traumatic brain injury suggest widespread persistent microglial activation, but there has been little 
study of persistent glial cell activity in brains of athletes with sports-related traumatic brain injury.
OBJECTIVE—To measure translocator protein 18 kDa (TSPO), a marker of activated glial cell 
response, in a cohort of National Football League (NFL) players and control participants, and to 
report measures of white matter integrity.
DESIGN, SETTING, AND PARTICIPANTS—This cross-sectional, case-control study included 
young active (n = 4) or former (n = 10) NFL players recruited from across the United States, and 
16 age-, sex-, highest educational level-, and body mass index-matched control participants. This 
study was conducted at an academic research institution in Baltimore, Maryland, from January 29, 
2015, to February 18, 2016.
MAIN OUTCOMES AND MEASURES—Positron emission tomography-based regional 
measures of TSPO using [11C]DPA-713, diffusion tensor imaging measures of regional white 
matter integrity, regional volumes on structural magnetic resonance imaging, and 
neuropsychological performance.
RESULTS—The mean (SD) ages of the 14 NFL participants and 16 control participants were 
31.3 (6.1) years and 27.6 (4.9) years, respectively. Players reported a mean (SD) of 7.0 (6.4) years 
(range, 1–21 years) since the last self-reported concussion. Using [11C]DPA-713 positron emission 
tomographic data from 12 active or former NFL players and 11 matched control participants, the 
NFL players showed higher total distribution volume in 8 of the 12 brain regions examined (P < .
004). We also observed limited change in white matter fractional anisotropy and mean diffusivity 
in 13 players compared with 15 control participants. In contrast, these young players did not differ 
from control participants in regional brain volumes or in neuropsychological performance.
CONCLUSIONS AND RELEVANCE—The results suggest that localized brain injury and 
repair, indicated by higher TSPO signal and white matter changes, may be associated with NFL 
play. Further study is needed to confirm these findings and to determine whether TSPO signal and 
white matter changes in young NFL athletes are related to later onset of neuropsychiatric 
symptoms.
Increasing evidence supports the complex role of microglia, the resident immune cells of the 
central nervous system, in response to brain injury and neurodegenerative processes.1 
Widespread persistent microglial activation has been detected in a limited number of small 
in vivo brain imaging studies of individuals months to years after a single traumatic brain 
injury (TBI).2,3 Nevertheless it is unclear whether prolonged microglial activation occurs 
after TBI or repeated TBI incurred through sports-related concussive and subconcussive 
injuries. New techniques designed to image markers of glial cell activation in vivo promise 
to help uncover whether sports-related TBI elicits acute and prolonged glial response.
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The translocator protein 18 kDa (TSPO) is normally expressed at low levels in brain tissue 
but is increased in expression by activated microglia, as well as reactive astrocytes.4 
Therefore, TSPO is a proposed biomarker for brain injury and repair that can now be 
measured in living patients using radiotracers and positron emission tomographic (PET) 
imaging.5,6 Recently, we characterized the use of [11C]DPA-713 with PET to image the 
distribution of TSPO in health and disease,7 including correction for the effect of a common, 
genetic polymorphism on [11C]DPA-713 binding to TSPO.8 In a cross-sectional pilot study 
of older former National Football League (NFL) players and control participants, TSPO PET 
signal was significantly higher in the right amygdala and bilateral supramarginal gyri of the 
players compared with control participants.9
In vivo study of brain tissue changes in athletes playing collision sports has largely focused 
on detection of white matter tract changes using diffusion tensor imaging (DTI), which is 
based on the estimates of water movement in brain tissue.10 Previous studies suggest 
widespread changes in white matter diffusion indices over one season of high school 
participation in a collision sport.11–13 White matter diffusion indices have also been reported 
in collegiate football players studied 6 months after concussion,14 although changed white 
matter integrity may be clinically silent in high school and collegiate athletes with TBI.11,13
Here we combined high-resolution brain [11C]DPA-713 PET with assessment of white 
matter integrity, regional volumes, and neuropsychological performance in a new population 
of young active and former NFL players. Data from players were compared with data from 
control participants who were matched to players in age, sex, highest educational level, and 
body mass index (calculated as weight in kilograms divided by height in meters squared). 
We tested the hypothesis that players have higher [11C]DPA-713 PET signal and altered 
white matter integrity compared with control participants. Rather than focusing on older 
former NFL players,9 we focused on young players because they are temporally closer to 
NFL play and at less risk for cerebrovascular disease, which may also generate positive 
signal on TSPO PET.15
Methods
Human Participants
A Johns Hopkins institutional review board approved this study, which was conducted from 
January 29, 2015, to February 18, 2016. All participants provided written informed consent. 
National Football League players engaged in active play and those who were recently retired 
(defined as within 12 years of stopping play) were recruited through personal referrals by 
one of the authors (C.J.N.) and word of mouth. Male control participants were recruited 
through local advertising and completed a careful clinical interview to ensure stable health.
Clinical Assessment and Neuropsychological Testing
Participants underwent a standardized examination by a board-certified psychiatrist that 
included questions about past and current athletic pursuits (including participation in 
football and TBI for the NFL players) and medical and psychiatric history, as well as family 
history of neuropsychiatric illness (including dementia and affective illness). Details about 
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NFL play and past concussion, as defined by the Quality Standards Subcommittee of the 
American Academy of Neurology,16 were obtained from the NFL players by self-report. 
Participants completed the 17-item Hamilton Depression Scale (HAM-D).17 Control 
participants denied history of substance dependence, neurological disorder, subjective 
cognitive symptoms, participation in collegiate or professional collision sports, and TBI. 
Participants denied current use of anti-inflammatory treatment, including over-the-counter 
medications, and all were assessed for TSPO (rs6971) genotype as previously described.7
Participants completed a battery of neuropsychological tests (eTable 1 in the Supplement), 
from which we chose representative tests for this study (eAppendix 1 in the Supplement).
In Vivo Brain Imaging
Radiotracer Synthesis and PET Acquisition—[11C]DPA-713 was synthesized as 
previously described18 and met all US Pharmacopeia Chapter 823 acceptance testing 
criteria. Radiochemical purity at end of synthesis was greater than 99%, with mean (SD) 
specific activity of 342 (83) GBq per micromole (9245 [2255] mCi/μmol) at time of 
injection. The mean (SD) injected dose was 684.0 (53.1) MBq. Key details about the 
dynamic PET acquisition are included in eAppendix 2 in the Supplement and are identical to 
those previously described.9
Magnetic Resonance Imaging Acquisition—Participants underwent brain magnetic 
resonance imaging (MRI) on a Phillips Achieva 3-T scanner for structural T1-weighted 
imaging (3-dimensional MPRAGE) with 1 × 1 × 1-mm resolution and DTI. Diffusion tensor 
imaging parameters included single-shot echoplanar imaging; b-value of 700 seconds/mm2; 
32 diffusion-weighting orientations with 5 b0 images; 70 gapless whole-brain axial sections 
of 2.2-mm thickness; matrix of 96 × 96, field of view of 212 × 212 mm, and zero-filled to 
256 × 256 mm. DtiStudio was used for data processing.19 Motion and eddy current were 
monitored and corrected with an in-house affine transformation with a cost function based 
on tensor fitting.20 Gradient tables were compensated for rotational motion. Tensor fitting 
was performed by a RESTORE-type in-house outlier rejection method.21
Data Analysis and Statistics
PET Data Analysis—The software package PMOD (version 3.3; PMOD Technologies 
Ltd) was used in the initial PET image processing and kinetic analysis. Interframe motion 
correction and PET-MRI coregistration were completed as previously described.9 Cortical 
reconstruction and volumetric segmentation of T1-weighted MRIs were performed with the 
FreeSurfer image analysis suite (http://surfer.nmr.mgh.harvard.edu/). Twelve regions of 
interest (ROIs), identical to those used previously,9 were selected for this study: right and 
left side hippocampus, parahippocampus, entorhinal cortex, amygdala, temporal pole, and 
supramarginal gyrus (eFigure 1 in the Supplement). Total cortical gray matter (GM) and 
total intracranial volume (ICV) were also defined using FreeSurfer for use in secondary 
analyses exploring the effect of (1) clinical characteristics on [11C]DPA-713 binding in GM 
and (2) ROI volume normalized to ICV on regional binding.18 The primary PET-based 
regional binding outcome was total distribution volume (VT).22
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Positron emission tomographic time-activity curves were generated for all participants using 
the ROI definitions. Based on the time-activity curves obtained, VT within each ROI was 
estimated using Logan graphical analysis23 (t* = 30 minutes) with the metabolite-corrected 
arterial plasma input function. Plasma free fraction (fP) was measured using rapid 
equilibrium dialysis as previously described18 and VT corrected for fP (VT/fP) was 
calculated.
DTI Data Analyses—Diffusion tensor imaging data were analyzed by automated white 
matter segmentation using MriStudio software.24,25 Briefly, an atlas with defined white 
matter regions (JHU “Eve” Atlas) was warped to each patient image using large deformation 
diffeomorphic metric mapping implemented in Diffeo-Map software. Fractional anisotropy 
(FA) and mean diffusivity (MD) values of the 8 predefined white matter structures (eFigure 
2 in the Supplement) were then measured using RoiEditor. These white matter regions were 
selected because they contain long fibers that collectively project from subcortical structures 
to widespread cortical tissue. Long axonal projections are potentially more vulnerable to 
axonal injury from rapid biomechanical forces induced by hits to the head.26 While studies 
implicate varied sites of white matter change after sports-related concussion,27 we focused 
on right and left side anterior, superior, and posterior corona radiata, as well as posterior 
thalamic radiation (PTR), because postseason changes in corona radiata and PTR have been 
observed in young athletes playing collision sports.11,12,28 Using a 3-dimensional atlas-
based approach, we overcame the limitation of tract-based methods in defining thalamic 
radiations, which are difficult to define using a 2-dimensional plane.29
Statistical Analysis
Statistical analyses of the primary PET outcome measure, regional VT, were performed with 
multivariate general linear modeling using SPSS Statistics (version 22.0; IBM Corp). We 
modeled the VT values obtained from the 12 selected ROIs based on their relationship to 
between-participant factors, including cohort (NFL player or control) and TSPO genotype 
(C/C: high affinity binder and C/T: mixed affinity binder) as independent fixed factors. 
Participants with genotype T/T were excluded from this analysis of PET data owing to the 
low affinity of [11C]DPA-713 for TSPO in individuals with T/T genotype. Similar analyses 
were repeated for regional values, VT/fP.
All other statistical analyses were performed using R (R Foundation for Statistical 
Computing).30 Demographic and clinical characteristics of NFL players vs control 
participants were compared using 2-sample t tests for continuous variables and Fisher exact 
test for categorical variables. Data were expressed as mean (SD) unless otherwise noted.
The threshold for significance in all statistical tests involving regional VT and regional 
volume measures was set as P < .004, taking into account the 12 ROIs using Bonferroni 
correction (0.05/12 ≈ 0.0042). The threshold for significance in all statistical tests involving 
the 8 white matter regions tested was set as P < .006 (approximately 0.05/8). Statistical 
significance was otherwise defined as P < .05, except where otherwise noted.
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Results
Study Population
Demographic characteristics and clinical characteristics of the NFL players and control 
participants are in Table 1. A total of 14 NFL players (4 active and 10 recently retired; ages 
24–39 years) and 16 control individuals (ages 21–37 years) participated. The 10 former NFL 
players ended NFL play in a period that spanned a range of 1 to 144 months prior to 
participation. Players reported a mean (SD) of 7.0 (6.4) years (range, 1–21 years) since the 
last self-reported concussion. Other self-reported details about NFL play are listed in eTable 
2 in the Supplement. On the HAM-D, 1 of the 14 players scored a 14, consistent with 
moderate depressive symptoms, and 1 player scored an 11, indicating mild depressive 
symptoms. All other participants were without depressive symptoms (HAM-D < 8). A 
summary of the number of participants in each cohort with data from [11C]DPA-713 PET 
imaging, structural MRI, DTI, and neuropsychological testing is in eTable 3 in the 
Supplement.
Neuropsychological Assessment of Former NFL Players and Control Participants
Three control participants did not undergo neuropsychological assessment. 
Neuropsychological test results from the 1 player with a HAM-D score of 14 were excluded 
owing to his scores on a performance validity measure (Word Memory Test).31 There were 
no differences in neuropsychological test scores between the remaining 13 players and 13 
control participants after correction for multiple comparisons (Table 2).
Structural MRI and Volumetric Analyses
No evidence of structural abnormality was present on T1-weighted MRI. Quantitative 
analysis of the MRI-based segmentation results for the 12 ROIs showed no significant 
difference between young NFL players and control participants in regional volume 
normalized to ICV (eTable 4 in the Supplement).
[11C]DPA-713 PET Imaging
Three control participants lacked arterial input function measurement, 1 control participant 
was excluded for T/T TSPO genotype, and 2 individuals (1 control and 1 player) had 
insufficient PET imaging due to scanner malfunction. One player (with C/C genotype) 
reported taking a creatine supplement and had unusually low binding across all brain regions 
(eTable 5 in the Supplement). Positron emission tomographic data from this outlier were 
removed from primary analyses because of previously published evidence that creatine use 
may lower TSPO PET signal.32 No other participants reported use of creatine supplements.
In 2-way analysis of variance, with genetic group (C/C vs C/T) and cohort (players vs 
control participants) as independent fixed factors, VT values between 12 NFL players and 11 
control participants differed significantly in the left and right hippocampus, left entorhinal 
cortex, left and right parahippocampal cortex, left and right supramarginal gyrus, and left 
temporal pole (Figure 1; eTable 5 in the Supplement). Correction of VT for plasma free 
fraction (VT/fP) did not change the results. Data from the 9 former players alone compared 
with control participants also revealed higher VT values in players in these regions (eTable 6 
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in the Supplement). Multivariate regressions using data from participants, controlling for 
genotype, showed no significant effect of ROI volume normalized to total ICV on VT in 
each of the 12 ROIs. Exploratory analyses of the effects of demographic and NFL play-
related characteristics on [11C]DPA-713 VT in GM showed NFL players had higher VT in 
GM compared with control participants, but there was no significant effect of age, race/
ethnicity, body mass index, or years of education on VT in GM (eTable 7 in the 
Supplement). Among the NFL cohort, there was also no observed effect of actively playing 
(vs being a former player), duration of retirement, years of play in the NFL, number of NFL 
games played, number of self-reported concussions, age at first self-reported concussion, or 
years since last self-reported concussion on VT in GM.
Diffusion Tensor Imaging
Diffusion tensor imaging data from 1 player and 1 control participant were excluded owing 
to severe motion artifact and claustrophobia limiting scan time, respectively. Of the 13 NFL 
players and 15 control participants with DTI data, FA values were significantly lower in the 
right posterior thalamic radiation of NFL players compared with control participants (Table 
3). Mean diffusivity values in the left anterior corona radiata were significantly higher in 
NFL players compared with control participants. Fractional anisotropy and MD values in the 
other white matter ROIs did not differ from those of control participants.
Discussion
Recent research supports an expanded role for microglia, the resident immune cells of the 
central nervous system, across the human lifespan and in disease.33–35 Because activated 
microglia can influence synaptic remodeling and white matter recovery after TBI,36·37 
characterization of glial activation close to the time of NFL play may elucidate the 
relationship between microglial response, tissue micro-structural organization, and 
symptoms. The increased expression of TSPO by activated glia (microglia and reactive 
astrocytes) is the basis of several promising PET-based imaging methods to measure brain 
injury and repair in vivo.6,38–42
The current study extends our earlier findings of higher regional [11C]DPA-713 VT values in 
older former NFL players compared with control participants9 to a new cohort of younger 
NFL players compared with matched control participants (Figure 1). We measured TSPO 
binding in the same temporal and parietal cortical regions as well as the mesial temporal 
lobe structures as in our previous study. Visual inspection of [11C]DPA-713 parametric PET 
images implicates high binding in the thalamus and midbrain regions in young NFL players 
as well (Figure 2). The collective results from this and our previous study suggest potential 
vulnerability of the supramarginal gyrus to injury from TBI in football that warrants further 
investigation. Furthermore, higher TSPO signal in the left temporal pole and mesial 
temporal lobe structures of young NFL players compared with control participants provides 
in vivo evidence of hypothesized vulnerability of these regions to biomechanical forces 
incurred through sports-related TBI.26
We aimed to assess TSPO signal in parallel with white matter organization, regional volume, 
and neuropsychological performance. Looking across the widespread white matter area 
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covered by bilateral subsections of the coronal radiata and bilateral PTR, we observed lower 
FA, a nonspecific but potential indicator of lower white matter integrity, in the right PTR of 
the NFL players compared with control participants. Mean diffusivity, often observed as 
inverse of FA and reflecting the magnitude of white matter change,10 was higher in NFL 
players compared with control participants in the left anterior corona radiata. Irrespective of 
these white matter diffusion findings, we did not see a difference in regional volumes 
normalized to ICV, nor difference in performance on selected neuropsychological tests 
between these cohorts of young individuals. Marked pathological changes to susceptible 
brain regions and associated cognitive, affective, and behavioral symptoms may take 
decades to emerge after participation in collision sport.26,43 Together our results support 
emerging evidence from mouse studies of persistent microglial activation after head trauma 
that may increase susceptibility to later cognitive deficits.44,45 Therefore, therapeutic and 
preventive interventions before onset of clinical decline may be possible.
Strengths and Limitations
A strength of this study is the focus on relatively young NFL players who are closer to the 
time of play and are less likely to have cerebrovascular disease, which is independently 
associated with inflammation and white matter changes. Still, the players in this study 
reported a mean (SD) of 7.0 (6.4) years since last concussion. The temporal relationship 
between increased TSPO expression and sports-related TBI may be best elucidated using a 
longitudinal design with [11C]DPA-713 PET imaging from the time of measured head 
impact. It is also important to note that [11C]DPA-713 PET signal is only an indirect 
measure of microglial activation in the living brain, and DTI outcome measures, such as FA 
and MD, are only indirectly representative of underlying white matter structure. Our results 
support further in vitro experiments of activated microglia and white matter tract anatomy 
directly in carefully selected postmortem tissue from players of all ages.46
Conclusions
By demonstrating higher TSPO PET signal and altered DTI indices in several brain regions 
of young NFL players, we support future use of [11C]DPA-713 PET and DTI to examine 
these markers associated with brain injury and repair in athletes playing collision sports. 
Because there is interest in targeting microglial pathways and immune modulation to prevent 
neurodegeneration,37,47,48 further human studies using [11C]DPA-713 PET and DTI in 
individuals with history of sports-related TBI may inform strategies for future translational 
research and immune-based interventions.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Key Points
Question
Is localized brain injury, indicated by higher translocator protein signal and white matter 
changes, linked to National Football League (NFL) play?
Findings
In this cross-sectional, case-control study of young NFL players compared with control 
participants, players showed higher translocator protein positron emission tomographic 
signal in 8 of 12 regions examined. Limited significant white matter changes were also 
observed in NFL players compared with control participants, although players and 
control participants did not differ in regional brain volumes or neuropsychological 
performance.
Meaning
These results suggest that localized brain injury may be associated with NFL play, 
although further study is needed to test links to onset of neuropsychiatric symptoms.
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Figure 1. Scatter Plots of Regional Total Distribution Volume Values in Active and Recently 
Retired National Football League (NFL) Players and Control Individuals Injected With 
[11C]DPA-713
Individual total distribution volume data from NFL and control cohorts are shown along 
with mean (SD) values. Using 2-way analysis of variance with genetic group (C/C vs C/T) 
and cohort (NFL vs control) as independent fixed factors, regional total distribution volume 
values in 8 of the 6 right and left side regions (12 total regions) were significantly higher 
than those of control participants. The threshold for significance after accounting for 
multiple comparisons was P < .06/12 = .004.
aP < .004.
bP < .001.
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Figure 2. Former National Football League (NFL) Players Demonstrate Higher Binding of 
[11C]DPA-713 Across Many Brain Regions Compared With the Brains of Age-, Sex-, Education-, 
and Body Mass Index-Matched Control Individuals
A, Mean parametric [11C]DPA-713 total distribution volume (VT) images displayed in 
groups of 3 views (left to right: axial, sagittal, and coronal) from 6 controls (left 3 views) 
and 5 NFL players (right 3 views) with C/T rs6971 genotype are presented. B, Mean 
parametric [11C]DPA-713 VT images from 5 controls (left 3 views) and 7 NFL players (right 
3 views) with C/C rs6971 genotype are presented.
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Table 1
Clinical and Demographic Characteristics
Characteristic
NFL
(n = 14)
Control
(n = 16) P Valuea
Age, mean (SD), y 31.3 (6.1) 27.6 (4.9)  .08
Race, No. (%)
 African American  3 (21)  3 (19)
>.99
 White 11 (79) 13 (81)
BMI, mean (SD) 30.8 (3.3) 28.5 (5.3)  .17
Duration of education, mean (SD), y 16.8 (1.0) 16.9 (2.1)  .80
rs6971 TSPO genotype, No. (%)
 C/C  7 (58)  5 (45)
 .68
 C/T  5 (42)  6 (55)
Players, No. (%)
 Active  4 (29) NA NA
 Retired 10 (71) NA NA
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); C/C, high affinity binder; C/T, 
mixed affinity binder; NA, not applicable; NFL, National Football League.
aP values for t test or Fisher exact test as appropriate. Threshold for significance, P < .05.
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Table 2
Neuropsychological Performance in NFL Players and Control Participants
Test
Mean (SD) [Range]
P Valueb
NFL Players
(n = 13)a
Controls
(n = 13)a
Wechsler Test of Adult Reading 110.4 (14.4)
[75–128]
117.3 (5.2)
[105–122]
.12
Mini-Mental State Examination 27.2 (1.7)
[24–29]
28.7 (1.3)
[26–30]
.02
Trail Making Test, s
 Part A 19.3 (4.2)
[13–25]
21.9 (6.9)
[15–38]
.25
 Part B 49.0 (19.4)
[26–93]
41.2 (9.8)
[24–56]
.21
Wechsler Adult Intelligence Scale-IV Coding, raw score 69.2 (14.3)
[45–97]
82.6 (13.9)
[62–104]
.03
Phonemic fluency, No. of words in 2 min 33.8 (11.3)
[22–58]
36.9 (8.4)
[27–54]
.43
CVLT-2
 Trials 1–5, raw score (of 80 possible) 60.2 (9.7)
[46–76]
68.3 (7.9)
[48–78]
.03
 Delayed free recall, raw score (of 16 possible) 14.2 (1.6)
[12–16]
15.0 (1.7)
[10–16]
.21
Abbreviations: CVLT, California Verbal Learning Test-2; NFL, National Football League.
a
Data from 1 NFL player with moderate depressive symptoms (Hamilton Depression Scale score = 14) was not included in this comparison of 
neuropsychological performance between cohorts because of a low score on the initial test of effort (Word Memory Test). Three of the 16 control 
participants in the study did not complete the neuropsychological assessment.
bP values from t tests, with threshold for significance defined as P < .05/8 = .006 accounting for multiple tests.
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